Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 8, 2025BloodOpen Access

Deep immune signature of immune-mediated aplastic anemia patients shows distinct subsets of regulatory T cells associated with response to treatment: Results from the phase 3, randomized EBMT race clinical trial

View Full Paper
Ask AI
Bookmark
Share

Authors

SGSıla GerlevikGNGiorgio NapolitaniRCRiley Cook

Discussion

Loading...

Member takes

Overview

Observational analysis shows regulatory T cells influence treatment response in immune-mediated aplastic anemia, suggesting immune profiling as a predictive tool.

Key Points

  • Complete response patients had a unique baseline profile with enriched naive Tregs, indicating response variation.
  • Analysis of treatment responses in aplastic anemia revealed distinct T cell subsets impacting outcomes after immune suppressive therapy.
  • Mass cytometry was used to define various T-cell and innate immune cell subsets across treatment arms in the trial.
  • These findings highlight the importance of regulatory T cell subsets in tailoring therapies for patients with aplastic anemia.

Cite This Study

Gerlevik et al. (2025) studied this question.

synapsesocial.com/papers/69362f7f4fa91c937236e5f6https://doi.org/10.1182/blood-2025-26
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comprehensive multiproteomic analysis reveals an inflammatory phenotype in immune aplastic anemia characterized by broad activation of antigen presenting cells and t helper/cytotoxic 1.17 immune responses2025
  2. 2Qualitative assessment of predictors of response to immunosuppressive therapy in aplastic anemia: A systematic literature review2025 · 1 citations
  3. 3Functional plasma cell signatures mark AML chemotherapy responders: Evidence from immune niche profiling2025
  4. 4Monocyte-T cells crosstalk orchestrates early graft-versus-leukemia immunity in Acute Myeloid Leukemia patients after allogeneic transplantation2025
  5. 5Comprehensive profiling of the bone marrow microenvironment reveals an exhausted immune signature associated with tumor burden in Acute Myeloid Leukemia2025